Trials / Completed
CompletedNCT04900636
Telemedicine for Patients With an Hybrid Closed Loop System
A Telemedicine Platform for Patients With Type 1 Diabetes Mellitus Treated With an Hybrid Closed Loop System
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective is to assess the impact on quality of life after a follow-up program using a telemedicine platform designed for patients with DM1 treated with an hybrid closed loop insulin infusion system. Open-label, randomized 1:1 controlled clinical trial during 12 months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Telemedicine Arm | Patients with DM1 ≥ 18 years of age, users of closed loop hybrid systems, assigned to a follow-up program using a telemedicine platform combined with face-to-face visits according to protocol. |
Timeline
- Start date
- 2021-05-01
- Primary completion
- 2023-01-27
- Completion
- 2023-01-27
- First posted
- 2021-05-25
- Last updated
- 2023-09-08
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04900636. Inclusion in this directory is not an endorsement.